SCHEMBL5504455

SCHEMBL5504455

N=C(N)c1ccc(-c2c[nH]c(C(CNc3ccc(C(N)=O)cc3)Cc3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK1 P06870 2/20 0.39
KLK5 Q9Y337 2/20 0.39
ITGB3 P05106 3/20 0.39
ITGA2B P08514 3/20 0.39
F10 P00742 5/20 0.38
F9 P00740 4/20 0.38
HDAC8 Q9BY41 2/20 0.38
PLAU P00749 1/20 0.37
HPN P05981 1/20 0.37
F2 P00734 3/20 0.36
PRSS1 P07477 3/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPK10 P53779 1/20 0.36
MRGPRX1 Q96LB2 1/20 0.36
NQO2 P16083 1/20 0.35
F11 P03951 1/20 0.35
KLKB1 P03952 1/20 0.35
PRKDC P78527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5513334 0.88 MYC (0.41) F9HDAC8MAPK8MAPK10F11
SCHEMBL392690 0.85 F9 (0.51) ITGB3ITGA2BF10F9HDAC8
SCHEMBL393253 0.85 F9 (0.51) ITGB3ITGA2BF10F9HDAC8
SCHEMBL393149 0.82 ITGB3 (0.50) ITGB3ITGA2BF10F9PLAU
SCHEMBL393165 0.80 F9 (0.48) F10F9F2KLKB1
SCHEMBL395016 0.80 F9 (0.51) KLK1ITGB3ITGA2BF10F9
SCHEMBL390032 0.80 F9 (0.55) ITGB3ITGA2BF10F9PLAU
SCHEMBL392266 0.78 CPA1 (0.42) F10HDAC8F11KLKB1
SCHEMBL390066 0.77 HDAC8 (0.42) F10HDAC8MAPK8MAPK10F11
SCHEMBL390067 0.77 HDAC8 (0.42) F10HDAC8MAPK8MAPK10F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773786-A2 FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS Bristol-Myers Squibb Company (US) 2007-04-18 EP disclosed
WO-2005123050-A2 FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-29 WO disclosed